申请人:Pfizer Inc.
公开号:US20020052401A1
公开(公告)日:2002-05-02
This invention relates to a series of substituted benzophenone and sulfone compounds of the formula I
1
wherein ring A, Z, Y, R and X are defined as in the specification, that exhibit activity as glycine transport inhibitors, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their use for the enhancement of cognition and the treatment of the positive and negative symptoms of schizophrenia and other psychoses in mammals, including humans.
这项发明涉及一系列符合以下式I的取代苯并酮和砜化合物:
其中环A、Z、Y、R和X的定义如规范中所述,这些化合物表现出作为甘氨酸转运抑制剂的活性,它们的药学上可接受的盐,含有它们的药物组合物,以及它们用于增强认知和治疗哺乳动物,包括人类,的精神分裂症和其他精神病阳性和阴性症状的用途。